A Double‐Blind Comparison of Haloperidol Oral Concentrate, Haloperidol Solutabs and Placebo in the Treatment of Chronic Schizophrenia

The Journal of Clinical Pharmacology and New Drugs

Volumn 13, Issue 2-3, 1973, Pages 99-110

  OTA, K Y ^a   KURLAND, A A ^a  

^a Spring Grove Hospital Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HALOPERIDOL; PLACEBO;

ARTICLE; CHRONIC DISEASE; CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; RATING SCALE; SCHIZOPHRENIA; SOLUTION AND SOLUBILITY; TABLET;

CHRONIC DISEASE; CLINICAL TRIALS; HALOPERIDOL; HUMAN; PLACEBOS; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; SOLUTIONS; TABLETS;

EID: 0015582092     PISSN: 00219754     EISSN: 15524604     Source Type: Journal    
DOI: 10.1002/j.1552-4604.1973.tb00259.x     Document Type: Article

References (12)

1. A comparison of haloperidol and trifluoperazine
2. Treatment of acute and chronic psychoses with haloperidol: review of clinical results
3. A review of clinical literature on haloperidol
4. Clinical efficacy of the butyrophenones as antipsychotic drugs
5. Clinical evaluation of neuroleptic drug action, particularly considering butyrophenones
6. Haloperidol and thioridazine in treatment of chronic schizophrenics
7. Haloperidol—new addition to the drug treatment of schizophrenia
8. The Brief Psychiatric Rating Scale
9. NOSIE‐30: a treatment‐sensitive ward behavior scale
10. Multiple Range and Multiple F Tests